Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas

被引:98
作者
Kubiatowski, T
Jang, TC
Lachyankur, MB
Salmonsen, R
Nabi, RR
Quesenberry, PJ
Litofsky, NS
Ross, AH
Recht, LD
机构
[1] Univ Massachusetts, Med Ctr, Dept Neurol, Worcester, MA 01655 USA
[2] Univ Massachusetts, Med Ctr, Dept Surg Neurosurg, Ctr Canc, Worcester, MA 01655 USA
[3] Univ Massachusetts, Med Ctr, Dept Pharmacol & Mol Toxicol, Ctr Canc, Worcester, MA 01655 USA
[4] Univ Massachusetts, Med Ctr, Dept Med, Ctr Canc, Worcester, MA 01655 USA
关键词
glioblastoma multiforme; tumor invasion; matrix metalloproteinase; lipid signaling pathway; phosphatidylinositol; 3-kinase; phosphatase and tensin homolog; gelatinase;
D O I
10.3171/jns.2001.95.3.0480
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Glioblastoma multiforme is the most malignant of the primary brain tumors and aggressively infiltrates surrounding brain tissue, resulting in distant foci within the central nervous system, thereby rendering this tumor surgically incurable. The recent findings that both phosphatidylinositol 3-kinase (PI 3-K) and the phosphatase and tensin homolog PTEN) regulate tumor cell invasiveness have led the authors to surmise that these lipid signaling molecules might play a role in regulating matrix metalloproteinases (MMPs), which are essential for tumor cell invasion. Methods. Using the C6 glioma cell line, which does not express measurable amounts of PTEN protein and in which in vitro invasiveness is MMP dependent, the authors determined that in vitro glioma cell invasiveness was significantly reduced when cells were preincubated overnight with LY294002 or wortmannin, two specific inhibitors of PI 3-K signaling. Next, using gelatin zymography, it was noted that these compounds significantly inhibited MMP-2 and MMP-9-activities. Moreover, the decrease in MMP activity correlated with the decrease in PI 3-K activity, as assessed by Akt phosphorylation. Finally, using semiquantitative reverse transcriptase-polymerase chain reaction. the authors demonstrated that LY294002 decreased messenger (m)RNA levels for both MMPs. Thus, these in vitro data indicate that PI 3-K signaling modulates gelatinase activity at the level of mRNA. Using immunostaining of phosphorylated Akt (p-Akt) as a measure of PI 3-K activity, the authors next assessed rat brains implanted with C6 cells. Compared with surrounding brain, there was marked p-Akt staining in C6 glioma cells and in neurons immediately adjacent to the tumor, but not in normal brain. The p-Akt staining in rumors was especially intense in perivascular areas. Using double-labeling techniques, colocalization of p-Akt with MMP-2 and MMP-9 was also noted in perivascular tumor areas. Conclusions. The increase in p-Akt staining within these PTEN-deficient gliomas is consistent with what would be predicted from unchecked PI 3-K signaling. Furthermore, the immunohistochemically detected colocalization of p-Akt and MMP-2 and MMP-9 supports the authors' in vitro studies and the proposed linkage between PI 3-K signaling and MMP activity in gliomas.
引用
收藏
页码:480 / 488
页数:9
相关论文
共 63 条
  • [41] PRODUCTION OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES-1 BY HUMAN BRAIN-TUMORS
    NAKAGAWA, T
    KUBOTA, T
    KABUTO, M
    SATO, K
    KAWANO, H
    HAYAKAWA, T
    OKADA, Y
    [J]. JOURNAL OF NEUROSURGERY, 1994, 81 (01) : 69 - 77
  • [42] PARKS WC, 1998, MATRIX METALLOPROTEI
  • [43] Price A, 1999, CLIN CANCER RES, V5, P845
  • [44] Expression and localization of 92 kDa type IV collagenase gelatinase B (MMP-9) in human gliomas
    Rao, JS
    Yamamoto, M
    Mohaman, S
    Gokaslan, ZL
    Fuller, GN
    StetlerStevenson, WG
    Rao, VH
    Liotta, LA
    Nicolson, GL
    Sawaya, RE
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1996, 14 (01) : 12 - 18
  • [45] RAO JS, 1993, CANCER RES, V53, P2208
  • [46] Rooprai HK, 1998, INT J ONCOL, V13, P1153
  • [47] Russell DS, 1989, PATHOLOGY TUMORS NER
  • [48] Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
    Shalinsky, DR
    Brekken, J
    Zou, H
    McDermott, CD
    Forsyth, P
    Edwards, D
    Margosiak, S
    Bender, S
    Truitt, G
    Wood, A
    Varki, NM
    Appelt, K
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 236 - 270
  • [49] Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion
    Shaw, LM
    Rabinovitz, I
    Wang, HHF
    Toker, A
    Mercurio, AM
    [J]. CELL, 1997, 91 (07) : 949 - 960
  • [50] PIK3CA is implicated as an oncogene in ovarian cancer
    Shayesteh, L
    Lu, YL
    Kuo, WL
    Baldocchi, R
    Godfrey, T
    Collins, C
    Pinkel, D
    Powell, B
    Mills, GB
    Gray, JW
    [J]. NATURE GENETICS, 1999, 21 (01) : 99 - 102